Our process is personalized, medically guided, and deeply rooted in functional wellness
In a phase 2 clinical trial, CagriSema reduced HbA1c by 2.2% (p = 0.075) in comparison with semaglutide 2.4 mg alone [101]
Book your consultation today to start healing stronger
In the event that impacted product is administered to a patient, there is an increased risk that severe adverse events such as invasive bacterial infection, including bacterial meningitis, septicemia, and limited adverse events such as fever, chills, malaise, and cutaneous abscess may occur
In the NHIS, the overall prevalence was 500 per 100,000 population, and the prevalence in women was 865 per 100,000
Got questions about BPC-157 Arginaate